248 related articles for article (PubMed ID: 18209868)
1. [Pseudo-Cushing states].
Romanholi DJ; Salgado LR
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1303-13. PubMed ID: 18209868
[TBL] [Abstract][Full Text] [Related]
2. [Pseudo-Cushing syndrome. Physiopathologic aspects and differential diagnosis].
Ceroni L; Cota D; Pasquali R
Minerva Endocrinol; 2000 Jun; 25(2):47-54. PubMed ID: 11189791
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
[TBL] [Abstract][Full Text] [Related]
4. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
[TBL] [Abstract][Full Text] [Related]
6. The difficulties of pseudo-Cushing's syndrome (or "non-neoplastic hypercortisolism").
Chabre O
Ann Endocrinol (Paris); 2018 Jun; 79(3):138-145. PubMed ID: 29716734
[TBL] [Abstract][Full Text] [Related]
7. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.
Gold PW; Loriaux DL; Roy A; Kling MA; Calabrese JR; Kellner CH; Nieman LK; Post RM; Pickar D; Gallucci W
N Engl J Med; 1986 May; 314(21):1329-35. PubMed ID: 3010108
[TBL] [Abstract][Full Text] [Related]
8. Harmful effects of functional hypercortisolism: a working hypothesis.
Tirabassi G; Boscaro M; Arnaldi G
Endocrine; 2014 Aug; 46(3):370-86. PubMed ID: 24282037
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of corticotropin-releasing hormone in the inferior petrosal sinuses of healthy volunteers, patients with Cushing's syndrome, and patients with pseudo-Cushing states.
Yanovski JA; Nieman LK; Doppman JL; Chrousos GP; Wilder RL; Gold PW; Kalogeras KT
J Clin Endocrinol Metab; 1998 May; 83(5):1485-8. PubMed ID: 9589643
[TBL] [Abstract][Full Text] [Related]
10. DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome).
Findling JW; Raff H
Eur J Endocrinol; 2017 May; 176(5):R205-R216. PubMed ID: 28179447
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic tests for Cushing's syndrome.
Nieman LK
Ann N Y Acad Sci; 2002 Sep; 970():112-8. PubMed ID: 12381546
[TBL] [Abstract][Full Text] [Related]
12. Pseudo-Cushing's syndrome: the role of alcohol.
Elias AN; Meshkinpour H; Valenta LJ; Grossman MK
J Clin Gastroenterol; 1982 Apr; 4(2):137-9. PubMed ID: 6282953
[TBL] [Abstract][Full Text] [Related]
13. Alcohol-induced Cushing syndrome. Hypercortisolism caused by alcohol abuse.
Besemer F; Pereira AM; Smit JW
Neth J Med; 2011; 69(7):318-23. PubMed ID: 21934176
[TBL] [Abstract][Full Text] [Related]
14. Pitfalls in the diagnosis and management of Cushing's syndrome.
Bansal V; El Asmar N; Selman WR; Arafah BM
Neurosurg Focus; 2015 Feb; 38(2):E4. PubMed ID: 25639322
[TBL] [Abstract][Full Text] [Related]
15. PseudoCushing: why a clinical challenge?
Pecori Giraldi F
J Endocrinol Invest; 2015 Oct; 38(10):1137-9. PubMed ID: 25916434
[No Abstract] [Full Text] [Related]
16. [Diagnosis and differential diagnosis of Cushing's syndrome].
Penezić Z; Zarković M; Vujović S; Drezgić M
Srp Arh Celok Lek; 2006; 134(11-12):558-66. PubMed ID: 17304774
[TBL] [Abstract][Full Text] [Related]
17. Pitfalls in the diagnosis of Cushing's syndrome.
Vilar L; Freitas Mda C; Faria M; Montenegro R; Casulari LA; Naves L; Bruno OD
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1207-16. PubMed ID: 18209858
[TBL] [Abstract][Full Text] [Related]
18. Circadian variation in Cushing's disease and pseudo-Cushing states by analysis of F and ACTH pulsatility.
Cunningham JM; Buxton OM; Weiss RE
J Endocrinol Invest; 2002 Oct; 25(9):791-9. PubMed ID: 12398238
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing hormone: from endocrinology to psychobiology.
Smith MA; Kling MA; Whitfield HJ; Brandt HA; Demitrack MA; Geracioti TD; Chrousos GP; Gold PW
Horm Res; 1989; 31(1-2):66-71. PubMed ID: 2656470
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]